188.8.131.52: 2-alkenal reductase [NAD(P)+]
This is an abbreviated version!
For detailed information about 2-alkenal reductase [NAD(P)+], go to the full flat file.
Word Map on EC 184.108.40.206
2-alkenal reductase, 2AER, AER, alkenal/one oxidoreductase, alkenal/one reductase, AOR, At-AER, At5g16970, AtAOR, bifunctional LTB4 12-hydroxydehydrogenase/15-oxo-prostaglandin 13-reductase, CS-670 double-bond reductase, CsAOR, Dbr1, double bond reductase, LTB4 12-HD/PGR, NADPH alkenal/one oxidoreductase, NADPH-dependent alkenal/one oxidoreductase
Disease on EC 220.127.116.11 - 2-alkenal reductase [NAD(P)+]
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Increased expression of prostaglandin reductase 1 in hepatocellular carcinomas from clinical cases and experimental tumors in rats.
NADPH alkenal/one oxidoreductase activity determines sensitivity of cancer cells to the chemotherapeutic alkylating agent irofulven.
Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase.